EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dissemination of OXA-23 carbapenemase-producing Proteus mirabilis and Escherichia coli is driven by transposon-carrying lineages in the UK

Roxana Zamudio, Karen Osman, Rachel Pike, Aiysha Chaudhry, Danièle Meunier, Nicole Stoesser, Rebecca Stretch, Jane F Turton, David Williams, Katie L Hopkins

Microbial Genomics · 2025

DOI: 10.1099/mgen.0.001502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, 2025. Verfasst von Roxana Zamudio und 9 weiteren Autor:innen. Beteiligte Einrichtung: AMR and HCAI Division, UK Health Security Agency (UKHSA), London, UK. Hauptthemen laut MEDLINE: Proteus mirabilis, Escherichia coli, beta-Lactamases, DNA Transposable Elements. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenem-resistant Enterobacterales are a significant threat to global public health. Here, we characterize bla OXA-23 -positive Proteus mirabilis ( n =8) and Escherichia coli ( n =3) isolates from human clinical samples collected between 2021 and 2024 in the UK. Whole-genome sequencing (WGS) was used to generate data, and a phylogenetic tree inferred from SNPs filtered for recombination was constructed to assess the genomic relatedness among the isolates. To provide an international context, we included publicly available genomes. Short-read mapping to a reference genome enabled reconstruction of the genomic neighbourhood around bla OXA-23 . Minimum inhibitory concentration (MIC) determination was performed using broth microdilution and results interpreted using the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. UK P. mirabilis isolates belonged to ST142 and formed a sub-clade descending from an ancestral cluster of French isolates with relatively few SNPs between them (9–39). E. coli ST38 isolates harboured bla OXA-23 and showed close genetic relatedness (12–15 SNPs) among themselves. In P. mirabilis , bla OXA-23 was associated with transposon Tn 6703 , while E. coli harboured a novel composite transposon, designated Tn 7816 , bordered by two copies of IS 26 and with three copies of bla OXA-23 . bla OXA-23 was integrated into the chromosome in all isolates. All isolates were resistant to amoxicillin/clavulanic acid (>32 mg l −1 ) and with meropenem MICs above the EUCAST screening cut-off (0.5–1 mg l −1 ). In conclusion, UK bla OXA-23 -positive P. mirabilis isolates belong to the same clonal lineage (ST142) previously reported in Belgium, Germany, Switzerland and France, suggesting introduction of this lineage into the UK. This is the first report of an E. coli ST38 lineage with chromosomally encoded bla OXA-23 located within a novel transposon Tn 7816 . WGS plays an important role in identifying the mechanism(s) of transmission of emerging carbapenemase genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteus mirabilisEscherichia colibeta-LactamasesDNA Transposable ElementsBacterial ProteinsHumansUnited KingdomWhole Genome SequencingMicrobial Sensitivity TestsPhylogenyAnti-Bacterial AgentsEscherichia coli InfectionsGenome, BacterialProteus InfectionsPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

Escherichia coliOXA-23Proteus mirabiliscarbapenemasetransposon

Substanzen

beta-LactamasesDNA Transposable ElementscarbapenemaseBacterial ProteinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • AMR and HCAI Division, UK Health Security Agency (UKHSA), London, UK.
  • Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, Public Health Microbiology - Reference Microbiology Division, UK Health Security Agency (UKHSA), London, UK.
  • Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
  • NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford, Oxford, UK.

Zitieren

APA

Zamudio, R., Osman, K., Pike, R., Chaudhry, A., Meunier, D., Stoesser, N., Stretch, R., Turton, J. F., Williams, D., & Hopkins, K. L. (2025). Dissemination of OXA-23 carbapenemase-producing Proteus mirabilis and Escherichia coli is driven by transposon-carrying lineages in the UK. Microbial Genomics. https://doi.org/10.1099/mgen.0.001502

Vancouver

Zamudio R, Osman K, Pike R, Chaudhry A, Meunier D, Stoesser N, et al. Dissemination of OXA-23 carbapenemase-producing Proteus mirabilis and Escherichia coli is driven by transposon-carrying lineages in the UK. Microbial Genomics. 2025. doi:10.1099/mgen.0.001502

BibTeX
@article{Zamudio2025,
  author = {Zamudio, Roxana and Osman, Karen and Pike, Rachel and Chaudhry, Aiysha and Meunier, Danièle and Stoesser, Nicole and Stretch, Rebecca and Turton, Jane F and Williams, David and Hopkins, Katie L},
  title = {Dissemination of OXA-23 carbapenemase-producing Proteus mirabilis and Escherichia coli is driven by transposon-carrying lineages in the UK},
  journal = {Microbial Genomics},
  year = {2025},
  doi = {10.1099/mgen.0.001502}
}
Kostenlos starten →